BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 21.70% | -22.19% | 1.58% | -27.70% | -11.80% |
| Total Depreciation and Amortization | 39.75% | -30.90% | -30.03% | -61.68% | 126.30% |
| Total Amortization of Deferred Charges | 1.78% | -39.77% | 23.85% | 29.75% | 51.67% |
| Total Other Non-Cash Items | -55.34% | 615.49% | -51.27% | 422.22% | -52.93% |
| Change in Net Operating Assets | 76.87% | -64.60% | 56.31% | 347.53% | -66.42% |
| Cash from Operations | 30.85% | -135.35% | 55.28% | 36.36% | -52.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -5.88% | 502.69% | -84.17% | -12.17% | 38.06% |
| Total Debt Repaid | 74.47% | -2,250.00% | 0.00% | 0.00% | -33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.07% | 490.03% | -84.23% | -15.16% | 42.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,159.04% | 91.05% | -358.22% | 139.36% | -122.98% |